Listed

Intelligent Bio Solutions Inc.

INBSNasdaqCIK 1725430HealthcareFiscal year ends Jun 30

Latest reported revenue, Q4 FY2026$1.1mRevenue, Q4 FY2026, three months to 2026-06-30$1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figureThree months to Jun 30, 2026, from the 10-K filed Aug 19, 2026.

Latest quarter: Q4 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$1.1mRevenue, Q4 FY2026, three months to 2026-06-30$1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure+35.8% on a year earlier
  • Gross margin46.8%Gross margin, Q4 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $536.6k. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Revenue: $1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure+7.1 pts on a year earlier
  • Operating margin−346.4%Operating margin, Q4 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$4.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Revenue: $1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure+21.7 pts on a year earlier
  • Net margin−341.0%Net margin, Q4 FY2026, three months to 2026-06-30. net income / revenueNet income: −$3.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Revenue: $1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure+25.1 pts on a year earlier
  • Diluted EPSnot reported (Diluted EPS not reported)No year-earlier figure to compare
  • Free cash flow−$3.2mFree cash flow, Q4 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$3.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Capital expenditure: $0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figureNo year-earlier figure to compare

Last eight quarters

Full statements
Revenue$1.1mGross margin 46.8%
Diluted EPS−$1.80, Q3 FY2026
Free cash flow−$3.2m, Q4 FY2026
Intelligent Bio Solutions Inc., key figures for the last eight quarters
Line itemUnitQ1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q4 FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31Q4 FY20262026-06-30Shape over the periods
Revenue$k872Revenue, Q1 FY2025, three months to 2024-09-30$872.3k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure607Revenue, Q2 FY2025, three months to 2024-12-31$607.5k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure729Revenue, Q3 FY2025, three months to 2025-03-31$728.9k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure844Revenue, Q4 FY2025, three months to 2025-06-30$843.9k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure1,112Revenue, Q1 FY2026, three months to 2025-09-30$1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure897Revenue, Q2 FY2026, three months to 2025-12-31$896.8k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure1,061Revenue, Q3 FY2026, three months to 2026-03-31$1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure1,146Revenue, Q4 FY2026, three months to 2026-06-30$1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure
Gross margin%39.8%Gross margin, Q1 FY2025, three months to 2024-09-30. gross profit / revenueGross profit: $346.8k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Revenue: $872.3k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure36.7%Gross margin, Q2 FY2025, three months to 2024-12-31. gross profit / revenueGross profit: $223.1k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Revenue: $607.5k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure46.8%Gross margin, Q3 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $341.4k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Revenue: $728.9k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure39.8%Gross margin, Q4 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $335.6k. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Revenue: $843.9k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure46.6%Gross margin, Q1 FY2026, three months to 2025-09-30. gross profit / revenueGross profit: $518.3k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Revenue: $1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure51.3%Gross margin, Q2 FY2026, three months to 2025-12-31. gross profit / revenueGross profit: $459.7k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Revenue: $896.8k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure50.5%Gross margin, Q3 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $535.4k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Revenue: $1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure46.8%Gross margin, Q4 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $536.6k. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Revenue: $1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure
Operating margin%(312.4%)Operating margin, Q1 FY2025, three months to 2024-09-30. operating income / revenueOperating income: −$2.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Revenue: $872.3k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure(372.8%)Operating margin, Q2 FY2025, three months to 2024-12-31. operating income / revenueOperating income: −$2.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Revenue: $607.5k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure(351.3%)Operating margin, Q3 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Revenue: $728.9k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure(368.1%)Operating margin, Q4 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$3.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Revenue: $843.9k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure(269.8%)Operating margin, Q1 FY2026, three months to 2025-09-30. operating income / revenueOperating income: −$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Revenue: $1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure(293.9%)Operating margin, Q2 FY2026, three months to 2025-12-31. operating income / revenueOperating income: −$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Revenue: $896.8k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure(277.8%)Operating margin, Q3 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$2.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Revenue: $1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure(346.4%)Operating margin, Q4 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$4.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Revenue: $1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure
Net margin%(307.9%)Net margin, Q1 FY2025, three months to 2024-09-30. net income / revenueNet income: −$2.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Revenue: $872.3k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure(370.3%)Net margin, Q2 FY2025, three months to 2024-12-31. net income / revenueNet income: −$2.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Revenue: $607.5k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure(349.0%)Net margin, Q3 FY2025, three months to 2025-03-31. net income / revenueNet income: −$2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Revenue: $728.9k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure(366.2%)Net margin, Q4 FY2025, three months to 2025-06-30. net income / revenueNet income: −$3.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Revenue: $843.9k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure(268.3%)Net margin, Q1 FY2026, three months to 2025-09-30. net income / revenueNet income: −$3.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Revenue: $1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure(298.6%)Net margin, Q2 FY2026, three months to 2025-12-31. net income / revenueNet income: −$2.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Revenue: $896.8k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure(269.9%)Net margin, Q3 FY2026, three months to 2026-03-31. net income / revenueNet income: −$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Revenue: $1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figure(341.0%)Net margin, Q4 FY2026, three months to 2026-06-30. net income / revenueNet income: −$3.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Revenue: $1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure
Diluted EPS$ per share(0.70)Diluted EPS, Q1 FY2025, three months to 2024-09-30−$0.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure(4.96)Diluted EPS, Q2 FY2025, three months to 2024-12-31−$4.96 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure(4.41)Diluted EPS, Q3 FY2025, three months to 2025-03-31−$4.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figurenot reported (Diluted EPS not reported)(0.35)Diluted EPS, Q1 FY2026, three months to 2025-09-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure(2.82)Diluted EPS, Q2 FY2026, three months to 2025-12-31−$2.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-12, accession 0001493152-26-006311.Report this figure(1.80)Diluted EPS, Q3 FY2026, three months to 2026-03-31−$1.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001493152-26-022617.Report this figurenot reported (Diluted EPS not reported)
Free cash flow$knot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)(2,917)Free cash flow, Q1 FY2026, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: −$2.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Capital expenditure: $70.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001493152-25-021751.Report this figure(1,636)Free cash flow, Q2 FY2026, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-12, accession 0001493152-26-006311. Derived: 6-month figure less the 3-month figure.Capital expenditure: $68.2k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-12, accession 0001493152-26-006311. Derived: 6-month figure less the 3-month figure.Report this figure(4,343)Free cash flow, Q3 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: −$4.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001493152-26-022617. Derived: 9-month figure less the 6-month figure.Capital expenditure: −$12.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001493152-26-022617. Derived: 9-month figure less the 6-month figure.Report this figure(3,182)Free cash flow, Q4 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$3.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Capital expenditure: $0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-08-19, accession 0001493152-26-039136. Derived: 12-month figure less the 9-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$4.2mGross margin 48.6%
Diluted EPS−$8.44, FY2026
Free cash flow−$12.1m, FY2026
Intelligent Bio Solutions Inc., key figures for the last five fiscal years
Line itemUnitFY20222022-06-30FY20232023-06-30FY20242024-06-30FY20252025-06-30FY20262026-06-30Shape over the periods
Revenue$m0.4Revenue, FY2022, twelve months to 2022-06-30$437.1k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2022-09-22, accession 0001493152-22-026526.Report this figure1.3Revenue, FY2023, twelve months to 2023-06-30$1.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-09-18, accession 0001493152-24-036953.Report this figure3.1Revenue, FY2024, twelve months to 2024-06-30$3.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-08-15, accession 0001641172-25-024279.Report this figure3.1Revenue, FY2025, twelve months to 2025-06-30$3.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figure4.2Revenue, FY2026, twelve months to 2026-06-30$4.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figure
Gross margin%not reported (Gross profit not reported)26.0%Gross margin, FY2023, twelve months to 2023-06-30. gross profit / revenueGross profit: $326.7k. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-09-18, accession 0001493152-24-036953.Revenue: $1.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-09-18, accession 0001493152-24-036953.Report this figure45.8%Gross margin, FY2024, twelve months to 2024-06-30. gross profit / revenueGross profit: $1.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-08-15, accession 0001641172-25-024279.Revenue: $3.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-08-15, accession 0001641172-25-024279.Report this figure40.8%Gross margin, FY2025, twelve months to 2025-06-30. gross profit / revenueGross profit: $1.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-19, accession 0001493152-26-039136.Revenue: $3.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figure48.6%Gross margin, FY2026, twelve months to 2026-06-30. gross profit / revenueGross profit: $2.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-19, accession 0001493152-26-039136.Revenue: $4.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figure
Operating margin%(1907.1%)Operating margin, FY2022, twelve months to 2022-06-30. operating income / revenueOperating income: −$8.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-08-23, accession 0001493152-23-029992.Revenue: $437.1k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2022-09-22, accession 0001493152-22-026526.Report this figure(1002.1%)Operating margin, FY2023, twelve months to 2023-06-30. operating income / revenueOperating income: −$12.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-09-18, accession 0001493152-24-036953.Revenue: $1.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-09-18, accession 0001493152-24-036953.Report this figure(330.5%)Operating margin, FY2024, twelve months to 2024-06-30. operating income / revenueOperating income: −$10.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-08-15, accession 0001641172-25-024279.Revenue: $3.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-08-15, accession 0001641172-25-024279.Report this figure(349.8%)Operating margin, FY2025, twelve months to 2025-06-30. operating income / revenueOperating income: −$10.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-19, accession 0001493152-26-039136.Revenue: $3.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figure(299.1%)Operating margin, FY2026, twelve months to 2026-06-30. operating income / revenueOperating income: −$12.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-19, accession 0001493152-26-039136.Revenue: $4.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figure
Net margin%(1900.1%)Net margin, FY2022, twelve months to 2022-06-30. net income / revenueNet income: −$8.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2023-08-23, accession 0001493152-23-029992.Revenue: $437.1k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2022-09-22, accession 0001493152-22-026526.Report this figure(845.9%)Net margin, FY2023, twelve months to 2023-06-30. net income / revenueNet income: −$10.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-09-18, accession 0001493152-24-036953.Revenue: $1.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-09-18, accession 0001493152-24-036953.Report this figure(326.4%)Net margin, FY2024, twelve months to 2024-06-30. net income / revenueNet income: −$10.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-08-15, accession 0001641172-25-024279.Revenue: $3.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-08-15, accession 0001641172-25-024279.Report this figure(346.2%)Net margin, FY2025, twelve months to 2025-06-30. net income / revenueNet income: −$10.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-19, accession 0001493152-26-039136.Revenue: $3.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figure(294.9%)Net margin, FY2026, twelve months to 2026-06-30. net income / revenueNet income: −$12.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-19, accession 0001493152-26-039136.Revenue: $4.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figure
Diluted EPS$ per share(11.33)Diluted EPS, FY2022, twelve months to 2022-06-30−$11.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2023-08-23, accession 0001493152-23-029992.Report this figure(127.00)Diluted EPS, FY2023, twelve months to 2023-06-30−$127.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-09-18, accession 0001493152-24-036953.Report this figure(6.38)Diluted EPS, FY2024, twelve months to 2024-06-30−$6.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-08-15, accession 0001641172-25-024279.Report this figure(20.04)Diluted EPS, FY2025, twelve months to 2025-06-30−$20.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figure(8.44)Diluted EPS, FY2026, twelve months to 2026-06-30−$8.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figure
Free cash flow$mnot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)(9.8)Free cash flow, FY2024, twelve months to 2024-06-30. operating cash flow − capital expenditureOperating cash flow: −$9.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-08-15, accession 0001641172-25-024279.Capital expenditure: $221.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-08-15, accession 0001641172-25-024279.Report this figure(9.9)Free cash flow, FY2025, twelve months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: −$9.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-19, accession 0001493152-26-039136.Capital expenditure: $231.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figure(12.1)Free cash flow, FY2026, twelve months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$11.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-19, accession 0001493152-26-039136.Capital expenditure: $125.7k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-08-19, accession 0001493152-26-039136.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Intelligent Bio Solutions Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
ARMISTICE CAPITAL, LLC2026-06-30$324.5k141,397Added+11,397
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$47.8k20,840Reduced−7,769
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$13.3k5,810Unchanged
UBS Group AG2026-06-30$13.2k5,735Added+5,363
VANGUARD FIDUCIARY TRUST CO2026-06-30$9.1k3,958Unchanged
Tower Research Capital LLC (TRC)2026-06-30$7.5k3,280Added+2,030
OSAIC HOLDINGS, INC.2026-06-30$460200Unchanged
BARCLAYS PLC2026-06-30$326142New+142

Recent filings

All 465 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Intelligent Bio Solutions Inc., recent filings
FiledFormWhat it isAccession number
2026-10-2121:00 ET10-K/AAnnual report, amendedPeriod 2026-06-300001493152-26-047925
2026-10-1321:00 ET8-K5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-046863
2026-09-1121:00 ET8-K8.01 Other events0001493152-26-042411
2026-09-0912:50 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-26-041901
2026-09-0221:00 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-041253
2026-09-0121:10 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-041055
2026-08-2821:20 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-040656
2026-08-1912:50 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-26-039140
2026-08-1912:30 ET10-KAnnual reportPeriod 2026-06-300001493152-26-039136
2026-08-1121:29 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-037206

Latest annual report

Form 10-K for the fiscal year ended Jun 30, 2026Filed Aug 19, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q1 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1725430
Tickers
INBS
Exchange
Nasdaq
SIC code
3841 Surgical & Medical Instruments & Apparatus
Sector
Healthcare
Fiscal year ends
Jun 30
Incorporated in
DE
Filer category
Non-accelerated filer<br>Smaller reporting company
Former names
GBS Inc. (to 2022-10-18); Glucose Biosensor Systems (Greater China) Holdings, Inc. (to 2019-09-19)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.